The analysis of the overall survival of patients with ccRCC and UC treated with conventional chemotherapy revealed that the Meflin-high groups tended to have worse outcomes than the Meflin-low groups (Supplementary Fig. S2B and Supplementary Table S1). The gene discussed is ISLR; the disease is nonpapillary renal cell carcinoma.